|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Pennathur A, Gibson MK, Jobe BA and
Luketich JD: Oesophageal carcinoma. Lancet. 381:400–412. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Han LC and Chen Y: Small and long
non-coding RNAs: Novel targets in perspective cancer therapy. Curr
Genomics. 16:319–326. 2015. View Article : Google Scholar
|
|
5
|
Carninci P and Hayashizaki Y: Noncoding
RNA transcription beyond annotated genes. Curr Opin Genet Dev.
17:139–144. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kung JT, Colognori D and Lee JT: Long
noncoding RNAs: Past, present, and future. Genetics. 193:651–669.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Andrey G and Duboule D: SnapShot: Hox gene
regulation. Cell. 156:8562014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Gomez-Maldonado L, Tiana M, Roche O,
Prado-Cabrero A, Jensen L, Fernandez-Barral A, Guijarro-Muñoz I,
Favaro E, Moreno-Bueno G, Sanz L, et al: EFNA3 long noncoding RNAs
induced by hypoxia promote metastatic dissemination. Oncogene.
34:2609–2620. 2015. View Article : Google Scholar
|
|
9
|
Yu WD, Wang H, He QF, Xu Y and Wang XC:
Long noncoding RNAs in cancer-immunity cycle. J Cell Physiol.
233:6518–6523. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hu L, Wu Y, Tan D, Meng H, Wang K, Bai Y
and Yang K: Up-regulation of long noncoding RNA MALAT1 contributes
to proliferation and metastasis in esophageal squamous cell
carcinoma. J Exp Clin Cancer Res. 34:72015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Li X, Wu Z, Mei Q, Li X, Guo M, Fu X and
Han W: Long non-coding RNA HOTAIR, a driver of malignancy, predicts
negative prognosis and exhibits oncogenic activity in oesophageal
squamous cell carcinoma. Br J Cancer. 109:2266–2278. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Tan D, Wu Y, Hu L, He P, Xiong G, Bai Y
and Yang K: Long noncoding RNA H19 is up-regulated in esophageal
squamous cell carcinoma and promotes cell proliferation and
metastasis. Dis Esophagus. 30:1–9. 2017.
|
|
13
|
Wan J, Deng D, Wang X, Wang X, Jiang S and
Cui R: LINC00491 as a new molecular marker can promote the
proliferation, migration and invasion of colon adenocarcinoma
cells. Onco Targets Ther. 12:6471–6480. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Xia L, Wang Y, Meng Q, Su X, Shen J, Wang
J, He H, Wen B, Zhang C and Xu M: Integrated bioinformatic analysis
of a competing endogenous RNA network reveals a prognostic
signature in endometrial cancer. Front Oncol. 9:4482019. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Gao Z, Fu P, Yu Z, Zhen F and Gu Y:
Comprehensive analysis of lncRNA-miRNA-mRNA network ascertains
prognostic factors in patients with colon cancer. Technol Cancer
Res Treat. 18:15330338198532372019. View Article : Google Scholar
|
|
16
|
Wang WJ, Li HT, Yu JP, Han XP, Xu ZP, Li
YM, Jiao ZY and Liu HB: A competing endogenous RNA network reveals
novel potential lncRNA, miRNA, and mRNA biomarkers in the prognosis
of human colon adenocarcinoma. J Surg Res. 235:22–33. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Fan CN, Ma L and Liu N: Systematic
analysis of lncRNA-miRNA-mRNA competing endogenous RNA network
identifies four-lncRNA signature as a prognostic biomarker for
breast cancer. J Transl Med. 16:2642018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kim D, Langmead B and Salzberg SL: HISAT:
A fast spliced aligner with low memory requirements. Nat Methods.
12:357–360. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ashburner M, Ball CA, Blake JA, Botstein
D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS, Eppig JT,
et al: Gene ontology: Tool for the unification of biology. The gene
ontology consortium. Nat Genet. 25:25–29. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
The Gene Ontology Consortium: The gene
ontology resource: 20 Years and still going strong. Nucleic Acids
Res. 47:D330–D338. 2019. View Article : Google Scholar
|
|
21
|
Shannon P, Markiel A, Ozier O, Baliga NS,
Wang JT, Ramage D, Amin N, Schwikowski B and Ideker T: Cytoscape: A
software environment for integrated models of biomolecular
interaction networks. Genome Res. 13:2498–2504. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wen J, Yang H, Liu MZ, Luo KJ, Liu H, Hu
Y, Zhang X, Lai RC, Lin T, Wang HY and Fu JH: Gene expression
analysis of pretreatment biopsies predicts the pathological
response of esophageal squamous cell carcinomas to
neo-chemoradiotherapy. Ann Oncol. 25:1769–74. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
24
|
Di S, Li M, Ma Z, Guo K, Li X and Yan X:
TRIP13 upregulation is correlated with poor prognosis and tumor
progression in esophageal squamous cell carcinoma. Pathol Res
Pract. 215:1524152019. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhou T, Fu H, Dong B, Dai L, Yang Y, Yan W
and Shen L: HOXB7 mediates cisplatin resistance in esophageal
squamous cell carcinoma through involvement of DNA damage repair.
Thorac Cancer. 11:3071–3085. 2020. View Article : Google Scholar :
|
|
26
|
Tiffon C: The impact of nutrition and
environmental epigenetics on human health and disease. Int J Mol
Sci. 19:34252018. View Article : Google Scholar :
|
|
27
|
Zhan XH, Jiao JW, Zhang HF, Li CQ, Zhao
JM, Liao LD, Wu JY, Wu BL, Wu ZY, Wang SH, et al: A three-gene
signature from protein-protein interaction network of LOXL2- and
actin-related proteins for esophageal squamous cell carcinoma
prognosis. Cancer Med. 6:1707–1719. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Fu L, Qin YR, Ming XY, Zuo XB, Diao YW,
Zhang LY, Ai J, Liu BL, Huang TX, Cao TT, et al: RNA editing of
SLC22A3 drives early tumor invasion and metastasis in familial
esophageal cancer. Proc Natl Acad Sci USA. 114:E4631–E4640. 2017.
View Article : Google Scholar
|
|
29
|
Liu SY, Chen W, Chughtai EA, Qiao Z, Jiang
JT, Li SM, Zhang W and Zhang J: PIK3CA gene mutations in Northwest
Chinese esophageal squamous cell carcinoma. World J Gastroenterol.
23:2585–2591. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Deveson IW, Hardwick SA, Mercer TR and
Mattick JS: The dimensions, dynamics, and relevance of the
mammalian noncoding transcriptome. Trends Genet. 33:464–478. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yan X, Hu Z, Feng Y, Hu X, Yuan J, Zhao
SD, Zhang Y, Yang L, Shan W, He Q, et al: Comprehensive genomic
characterization of long non-coding RNAs across human cancers.
Cancer Cell. 28:529–540. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Washietl S, Kellis M and Garber M:
Evolutionary dynamics and tissue specificity of human long
noncoding RNAs in six mammals. Genome Res. 24:616–628. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ning L, Li Z, Wei D, Chen H and Yang C:
LncRNA, NEAT1 is a prognosis biomarker and regulates cancer
progression via epithelial-mesenchymal transition in clear cell
renal cell carcinoma. Cancer Biomark. 19:75–83. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Sugihara H, Ishimoto T, Miyake K, Izumi D,
Baba Y, Yoshida N, Watanabe M and Baba H: Noncoding RNA expression
aberration is associated with cancer progression and is a potential
biomarker in esophageal squamous cell carcinoma. Int J Mol Sci.
16:27824–27834. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Fu M, Zou C, Pan L, Liang W, Qian H, Xu W,
Jiang P and Zhang X: Long noncoding RNAs in digestive system
cancers: Functional roles, molecular mechanisms, and clinical
implications (Review). Oncol Rep. 36:1207–1218. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Chen C, Zheng Q, Kang W and Yu C: Long
non-coding RNA LINC00472 suppresses hepatocellular carcinoma cell
proliferation, migration and invasion through miR-93-5p/PDCD4
pathway. Clin Res Hepatol Gastroenterol. 43:436–445. 2019.
View Article : Google Scholar
|
|
37
|
Gong P, Qiao F, Wu H, Cui H, Li Y, Zheng
Y, Zhou M and Fan H: LncRNA UCA1 promotes tumor metastasis by
inducing miR-203/ZEB2 axis in gastric cancer. Cell Death Dis.
9:11582018. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Yang C, Pan Y and Deng SP: Downregulation
of lncRNA CCAT1 enhances 5-fluorouracil sensitivity in human colon
cancer cells. BMC Mol Cell Biol. 20:92019. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Evan GI and Vousden KH: Proliferation,
cell cycle and apoptosis in cancer. Nature. 411:342–348. 2001.
View Article : Google Scholar : PubMed/NCBI
|
